Bystolic: payments to doctors
Payments that named Bystolic as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 23,827
- Transactions
- 85,272
- Average per transaction
- $14
The per-transaction average — $14 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,827 providers the average total is $48, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $1,022,424 | 88.6% |
| AbbVie | $131,610 | 11.4% |